236 related articles for article (PubMed ID: 27348630)
1. Searching for New Leads for Tuberculosis: Design, Synthesis, and Biological Evaluation of Novel 2-Quinolin-4-yloxyacetamides.
Pitta E; Rogacki MK; Balabon O; Huss S; Cunningham F; Lopez-Roman EM; Joossens J; Augustyns K; Ballell L; Bates RH; Van der Veken P
J Med Chem; 2016 Jul; 59(14):6709-28. PubMed ID: 27348630
[TBL] [Abstract][Full Text] [Related]
2. Design, development of new synthetic methodology, and biological evaluation of substituted quinolines as new anti-tubercular leads.
Tanwar B; Kumar A; Yogeeswari P; Sriram D; Chakraborti AK
Bioorg Med Chem Lett; 2016 Dec; 26(24):5960-5966. PubMed ID: 27839684
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.
de Souza MV; Pais KC; Kaiser CR; Peralta MA; de L Ferreira M; Lourenço MC
Bioorg Med Chem; 2009 Feb; 17(4):1474-80. PubMed ID: 19188070
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of novel quinoline-based carboxylic hydrazides as anti-tubercular agents.
Chander S; Ashok P; Cappoen D; Cos P; Murugesan S
Chem Biol Drug Des; 2016 Oct; 88(4):585-91. PubMed ID: 27203404
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, antituberculosis studies and biological evaluation of new quinoline derivatives carrying 1,2,4-oxadiazole moiety.
Shruthi TG; Eswaran S; Shivarudraiah P; Narayanan S; Subramanian S
Bioorg Med Chem Lett; 2019 Jan; 29(1):97-102. PubMed ID: 30448235
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, biological evaluation and molecular modelling studies of novel quinoline derivatives against Mycobacterium tuberculosis.
Upadhayaya RS; Vandavasi JK; Vasireddy NR; Sharma V; Dixit SS; Chattopadhyaya J
Bioorg Med Chem; 2009 Apr; 17(7):2830-41. PubMed ID: 19285414
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of novel triazole, urea and thiourea derivatives of quinoline against Mycobacterium tuberculosis.
Upadhayaya RS; Kulkarni GM; Vasireddy NR; Vandavasi JK; Dixit SS; Sharma V; Chattopadhyaya J
Bioorg Med Chem; 2009 Jul; 17(13):4681-92. PubMed ID: 19457676
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of dihydroquinoline carboxamide derivatives as anti-tubercular agents.
Kumar G; Sathe A; Krishna VS; Sriram D; Jachak SM
Eur J Med Chem; 2018 Sep; 157():1-13. PubMed ID: 30064024
[TBL] [Abstract][Full Text] [Related]
9. Design, diversity-oriented synthesis and structure activity relationship studies of quinolinyl heterocycles as antimycobacterial agents.
Rachakonda V; Alla M; Kotipalli SS; Ummani R
Eur J Med Chem; 2013; 70():536-47. PubMed ID: 24189497
[TBL] [Abstract][Full Text] [Related]
10. Ring-substituted quinolines as potential anti-tuberculosis agents.
Vangapandu S; Jain M; Jain R; Kaur S; Singh PP
Bioorg Med Chem; 2004 May; 12(10):2501-8. PubMed ID: 15110831
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and evaluation of acridine and fused-quinoline derivatives as potential anti-tuberculosis agents.
Muscia GC; Buldain GY; Asís SE
Eur J Med Chem; 2014 Feb; 73():243-9. PubMed ID: 24412719
[TBL] [Abstract][Full Text] [Related]
12. Substituted 4-methylquinolines as a new class of anti-tuberculosis agents.
Jain R; Vaitilingam B; Nayyar A; Palde PB
Bioorg Med Chem Lett; 2003 Mar; 13(6):1051-4. PubMed ID: 12643909
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological evaluation and 3D QSAR study of 2,4-disubstituted quinolines as anti-tuberculosis agents.
Patel SR; Gangwal R; Sangamwar AT; Jain R
Eur J Med Chem; 2015 Mar; 93():511-22. PubMed ID: 25747550
[TBL] [Abstract][Full Text] [Related]
14. Antimycobacterial activity of natural products and synthetic agents: pyrrolodiquinolines and vermelhotin as anti-tubercular leads against clinical multidrug resistant isolates of Mycobacterium tuberculosis.
Ganihigama DU; Sureram S; Sangher S; Hongmanee P; Aree T; Mahidol C; Ruchirawat S; Kittakoop P
Eur J Med Chem; 2015 Jan; 89():1-12. PubMed ID: 25462220
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel class of quinoline-oxadiazole hybrids as anti-tuberculosis agents.
Jain PP; Degani MS; Raju A; Anantram A; Seervi M; Sathaye S; Ray M; Rajan MGR
Bioorg Med Chem Lett; 2016 Jan; 26(2):645-649. PubMed ID: 26675440
[TBL] [Abstract][Full Text] [Related]
16. Rational drug design based synthesis of novel arylquinolines as anti-tuberculosis agents.
Jain PP; Degani MS; Raju A; Ray M; Rajan MG
Bioorg Med Chem Lett; 2013 Nov; 23(22):6097-105. PubMed ID: 24095091
[TBL] [Abstract][Full Text] [Related]
17. Anti-tubercular activity of novel 4-anilinoquinolines and 4-anilinoquinazolines.
Asquith CRM; Fleck N; Torrice CD; Crona DJ; Grundner C; Zuercher WJ
Bioorg Med Chem Lett; 2019 Sep; 29(18):2695-2699. PubMed ID: 31378571
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, biological evaluation and 3D-QSAR study of hydrazide, semicarbazide and thiosemicarbazide derivatives of 4-(adamantan-1-yl)quinoline as anti-tuberculosis agents.
Patel SR; Gangwal R; Sangamwar AT; Jain R
Eur J Med Chem; 2014 Oct; 85():255-67. PubMed ID: 25089809
[TBL] [Abstract][Full Text] [Related]
19. Preparation and in vitro evaluation of benzylsulfanyl benzoxazole derivatives as potential antituberculosis agents.
Klimesová V; Kocí J; Waisser K; Kaustová J; Möllmann U
Eur J Med Chem; 2009 May; 44(5):2286-93. PubMed ID: 18694614
[TBL] [Abstract][Full Text] [Related]
20. Identification and synthesis of novel inhibitors of mycobacterium ATP synthase.
Surase YB; Samby K; Amale SR; Sood R; Purnapatre KP; Pareek PK; Das B; Nanda K; Kumar S; Verma AK
Bioorg Med Chem Lett; 2017 Aug; 27(15):3454-3459. PubMed ID: 28587823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
